2Martin K J, Chen SF, Clark GM, et al. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells [J]. J Natl Cancer Inst, 1994, 86:608-613. 被引量：1
3Pratt R, Vallis LM, Lim CW, et al. Mitochondrial creatine kinase in cancer patients [J]. Pathology,1987,19:162-165. 被引量：1
4Kanemitsu F, Kawanishi I, Mizushima J, et al. Mitochondrial creatine kinase as a tumor-associated marker [J]. Clin Chim Acta, 1984,138 : 175-183. 被引量：1
5Wyss M, Smeitink J, Wevers RA, et al. Mitochondrial creatine kinase:a key enzyme of aerobic energy metabolism[J]. Biochim Biophys Acta, 1992, 1102:119-166. 被引量：1
6Crompto M. The mitochondrial permeability transition pore and its role in cell death[J]. Biochem J, 1999,341 : 233-249. 被引量：1
7Sehiemann S, Sehwirzke M, Brunner N, et al. Molecular analysis of two mammary carcinoma cell lines at the transcriptionallevel as a model system for progression of breast cancer [J]. Clin Exp Metastasis,1998,16 : 129-139. 被引量：1
8Kornacker M, Schlattner U, Wallimann T, et al.Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis[J]. Int J Cancer, 2001, 94:513-519. 被引量：1
9Lee YC, Chang K J, Lu FJ, et al. Serum macro creatine kinase type 2 as a tumor marker in lung cancer:compariosn with carcinoembryonic antigen [J]. J Formos Med Assoc, 1990, 89:104-109. 被引量：1
10Nilsson O, Johansson C, Glimelius B, et al. Sensitivity and specificty of CA242 in gastro-intestinal cancer. A comparison with CEA, CASO and CA199[J]. Br J Cancer, 1992, 65:215-221. 被引量：1
